Skip to main content
. 2014 Feb;21(1):e29–e40. doi: 10.3747/co.21.1311

FIGURE 8.

FIGURE 8

Tornado diagram for model parameters with the largest impact on the incremental cost-effectiveness ratios (icers) for azacitidine (Vidaza: Celgene Corporation, Summit, NJ, U.S.A.) versus standard-dose chemotherapy (sdc). os = overall survival; qaly = quality-adjusted life years.